The loss of CAP1 expression affects the breast cancer cell cycle (Yu et al., 2014), retards the glioma cells proliferation (Bao et al., 2016; Fan et al., 2016) and inhibits cell cycle progression in epithelial ovarian cancer cells (Hua et al., 2015). This evidence concerns the gene CAP1 and breast carcinoma.